Physiology-Guided Complete Revascularization in Elderly Adults with Complex Disease


Complete revascularization in patients with acute myocardial infarction (AMI) and multivessel coronary artery disease has consistently shown clinical benefits in reducing major ischemic events. However, the applicability of this strategy in elderly patients with non-culprit lesions of high anatomical complexity is still subject to controversy. Clinical decisions in this group are often influenced by the perception of high risk, both due to age and to the presence of challenging angiographic characteristics such as severe calcification, true bifurcations, or extensive lesions.

In this context, Sarti et al. conducted a subanalysis of the FIRE study, in which they assessed the clinical impact of a physiology-guided complete revascularization strategy in patients aged ≥75 years with AMI, according to the anatomical complexity of non-culprit lesions, comparing it with culprit-lesion revascularization only.

Complexity was angiographically defined by the presence of severe calcification, ostial lesions, true bifurcations (>2.5 mm), in-stent restenosis, or long lesions (>28 mm). Researchers included a total of 1445 patients aged ≥75 years hospitalized for AMI (with or without ST-segment elevation) and with at least one functionally assessable non-culprit lesion.

The population was divided into two subgroups: patients with at least one complex non-culprit lesion (44%) and those without complex lesions (56%). At three years, patients with complex lesions had a higher incidence of MACE (major adverse cardiovascular events: death, AMI, stroke, or ischemia-driven revascularization), as well as of individual events such as AMI (9.4% vs. 6.5%) and need for repeat revascularization (9.8% vs. 6.1%), compared with those without complex lesions. 

Read also: Use of DCB in Coronary Territory: Position Document of the Academic Research Consortium.

Nevertheless, this higher baseline risk did not negate the benefits of the complete revascularization strategy: in both subgroups, this approach was associated with a significant reduction in the primary event (in the complex lesion group, adjusted hazars ratio [HR] 0.75 [95% confidence interval (CI): 0.56–0.99], and in the non-complex lesion group, adjusted HR 0.71 [95% CI: 0.53–0.95]).

This finding underscores the relevance of physiology: even in technically high-risk anatomies, physiology-guided complete revascularization maintains its efficacy without increasing safety events such as bleeding, stroke, or acute kidney injury.

Conclusions

This study challenges the conservative clinical approach often adopted in elderly or complex coronary anatomy patients. The evidence highlights that advanced age and anatomical complexity should not be barriers to offering optimal treatment. Therapeutic decisions should be guided more by coronary functionality than by anatomy in itself.

Original Title: Complete Revascularization in Older Patients With Myocardial Infarction With or Without Complex Nonculprit Lesions.

Reference: Sarti A, Erriquez A, Dal Passo B, Casella G, Guiducci V, Moreno R, Escaned J, Marchini F, Cocco M, Verardi FM, Clò S, Caglioni S, Farina J, Barbato E, Vadalà G, Cavazza C, Capecchi A, Gallo F, Campo G, Biscaglia S. Complete Revascularization in Older Patients With Myocardial Infarction With or Without Complex Nonculprit Lesions. Circ Cardiovasc Interv. 2025 Oct 3:e015902. doi: 10.1161/CIRCINTERVENTIONS.125.015902. Epub ahead of print. PMID: 41039960.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...

CRT 2026 | Clopidogrel vs Aspirin as Long-Term Monotherapy After Coronary Angioplasty

The use of aspirin as chronic antiplatelet therapy after percutaneous coronary intervention (PCI) has historically been the standard recommended by international guidelines. However, recent...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...